What is Cytokinetics's operating lease ROU assets?

Cytokinetics (CYTK) reported operating lease ROU assets of $74.55M in Q1 2026.

How has Cytokinetics's operating lease ROU assets changed year-over-year?

Cytokinetics's operating lease ROU assets decreased by 3.7% year-over-year, from $77.44M to $74.55M.

What is the long-term trend for Cytokinetics's operating lease ROU assets?

Over 5 years (2020 to 2025), Cytokinetics's operating lease ROU assets has grown at a 91.8% compound annual growth rate (CAGR), from $2.92M to $75.98M.

Cytokinetics CYTK Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Boston ScientificBSX

——

Other financials

Income statement

See full

Revenue$19.4M+1,126%

Operating income-$183.6M-18.0%

Net income-$206.0M-27.7%

EPS (diluted)-$1.67-22.8%

Balance sheet

See full

Cash & equivalents$129.8M+76.2%

Total debt$418.2M+75.8%

Total equity-$826.6M-210%

Total assets$1.3B+0.7%

Cash flow

See full

Operating cash flow-$145.5M-10.5%

CapEx$5.9M+4.7%

Free cash flow-$151.4M-10.3%

Valuation

See full

Market cap$10.7B+70.6%

Enterprise value$10.98B+70.7%

P/S101.1×-225×

Profitability

See full

Operating margin-605.1%-268pp

Net margin-784%-337pp

FCF margin-518.8%-223pp

Returns & leverage

See full

Return on equity-337.6%—

Debt / equity2.2×—

Current ratio4.2×-1.8×

Where this comes from

Reported directly by Cytokinetics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytokinetics's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cytokinetics's operating lease ROU assets?: Cytokinetics (CYTK) reported operating lease ROU assets of $74.55M in Q1 2026.
How has Cytokinetics's operating lease ROU assets changed year-over-year?: Cytokinetics's operating lease ROU assets decreased by 3.7% year-over-year, from $77.44M to $74.55M.
What is the long-term trend for Cytokinetics's operating lease ROU assets?: Over 5 years (2020 to 2025), Cytokinetics's operating lease ROU assets has grown at a 91.8% compound annual growth rate (CAGR), from $2.92M to $75.98M.